Key Finding: Kenya launches ambitious strategy to manufacture its own vaccines and health products

ბოლო განახლება: 22/08/2026 07:29

ავტორი:

0 Min Read

Kenya has adopted a comprehensive strategy to manufacture vaccines and health products locally through 2030, reducing import dependency and strengthening East African supply chain resilience, according to the World Health Organization Africa Regional Office. — Photo by Maksim Goncharenok on Pexels (Pexels License)

1 min read|37 words

Kenya's five-year manufacturing strategy (2026–2030) targets local vaccine and health product production. The initiative responds to supply chain vulnerabilities exposed by COVID-19 and positions East Africa for greater pharmaceutical independence.

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Key Finding

📰 Read the full article: Kenya launches ambitious strategy to manufacture its own vaccines and health products →

Share This Article

ავტორი:Prof. Giorgi Pkhakadze

Follow:

Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Key Finding: Kenya launches ambitious strategy to manufacture its own vaccines and health products

Submit Your Paper →

Adverse Childhood Experiences in Rural India: Why Western Frameworks Fall Short

Maternal RSV Vaccine Cuts Infant Hospitalisation Risk by Half, Real-World Data Show

Brain enzyme GSK-3β: How lithium may slow aging at the molecular level

Submit Your Paper to GMJ

Company

You Might Also Like